Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2016, Article ID 2464953, 6 pages
http://dx.doi.org/10.1155/2016/2464953
Research Article

Decreased Serum 25-hydroxyvitamin D Level Causes Interventricular Septal Hypertrophy in Patients on Peritoneal Dialysis: Cardiovascular Aspects of Endogenous Vitamin D Deficiency

1Department of Internal Medicine and Nephrology, Bagcilar Education and Research Hospital, Istanbul, Turkey
2Department of Cardiology, Bagcilar Education and Research Hospital, Istanbul, Turkey
3Department of Internal Medicine, Bagcilar Education and Research Hospital, Istanbul, Turkey
4Department of Internal Medicine and Nephrology, Bakırkoy Sadi Konuk Education and Research Hospital, Istanbul, Turkey
5Department of Biochemistry, Bagcilar Education and Research Hospital, Istanbul, Turkey
6Department of Internal Medicine and Nephrology, Sevket Yılmaz Education and Research Hospital, Bursa, Turkey
7Department of Internal Medicine and Nephrology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey

Received 11 July 2016; Accepted 1 November 2016

Academic Editor: Alessandro Amore

Copyright © 2016 Bennur Esen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Chen, G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky, “Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation,” The Journal of Immunology, vol. 179, no. 3, pp. 1634–1647, 2007. View at Publisher · View at Google Scholar
  2. K. A. Nibbelink, D. X. Tishkoff, S. D. Hershey, A. Rahman, and R. U. Simpson, “1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3-5, pp. 533–537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. D. O'Connell, J. E. Berry, A. K. Jarvis, M. J. Somerman, and R. U. Simpson, “1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 272, no. 4, pp. H1751–H1758, 1997. View at Google Scholar · View at Scopus
  4. J. J. Green, D. A. Robinson, G. E. Wilson, R. U. Simpson, and M. V. Westfall, “Calcitriol modulation of cardiac contractile performance via protein kinase C,” Journal of Molecular and Cellular Cardiology, vol. 41, no. 2, pp. 350–359, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” The New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. T.-H. Kuo, D.-C. Yang, W.-H. Lin et al., “Compliance index, a marker of peripheral arterial stiffness, may predict renal function decline in patients with chronic kidney disease,” International Journal of Medical Sciences, vol. 12, no. 7, pp. 530–537, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. H. F. Deluca and M. T. Cantorna, “Vitamin D: its role and uses in immunology,” FASEB Journal, vol. 15, no. 14, pp. 2579–2585, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Pilz, A. Tomaschitz, C. Drechsler, and R. A. de Boer, “Vitamin D deficiency and heart disease,” Kidney International Supplements, vol. 1, no. 4, pp. 111–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. H. Mose, H. Vase, T. Larsen et al., “Cardiovascular effects of cholecalciferol treatment in dialysis patients—a randomized controlled trial,” BMC Nephrology, vol. 15, article 50, 2014. View at Publisher · View at Google Scholar
  10. “K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease,” American Journal of Kidney Diseases, vol. 42, pp. S1–S201, 2003.
  11. G. A. Block and F. K. Port, “Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management,” American Journal of Kidney Diseases, vol. 35, no. 6, pp. 1226–1237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. K. Leypold and A. K. Cheung, “Evaluating volume status in hemodialysis patients,” Advances in Renal Replacement Therapy, vol. 5, pp. 64–74, 1998. View at Google Scholar
  13. R. M. Lang, M. Bierig, R. B. Devereux et al., “Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology,” Journal of the American Society of Echocardiography, vol. 18, no. 12, pp. 1440–1463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. “Causes of death,” American Journal of Kidney Diseases, vol. 34, no. 2, supplement 1, pp. S87–S94, 1999. View at Publisher · View at Google Scholar
  15. H. Taskapan, I. Sahin, P. Tam, and T. Sikaneta, “Vitamin D and kidney,” International Journal of Endocrinology, vol. 2013, Article ID 164103, 2 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Ravani, F. Malberti, G. Tripepi et al., “Vitamin D levels and patient outcome in chronic kidney disease,” Kidney International, vol. 75, no. 1, pp. 88–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. J. Wang and Q. S. Wells, “Vitamin D deficiency and heart failure risk. Not so black and white?” JACC: Heart Failure, vol. 3, no. 5, pp. 357–359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. M. P. Pekkanen, O. Ukkola, P. Hedberg et al., “Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 25, no. 5, pp. 471–478, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Drechsler, M. Verduijn, S. Pilz et al., “Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study,” Nephrology Dialysis Transplantation, vol. 26, no. 3, pp. 1024–1032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Xanthakis, D. M. Enserro, J. M. Murabito et al., “Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study,” Circulation, vol. 130, no. 19, pp. 1676–1683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. G. N. Thomas, B. Ó. Hartaigh, J. A. Bosch et al., “Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen risk and cardiovascular health (LURIC) study,” Diabetes Care, vol. 35, no. 5, pp. 1158–1164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Santoro, D. Caccamo, S. Lucisano et al., “Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system,” BioMed Research International, vol. 2015, Article ID 145828, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Yokoyama, A. Nakashima, M. Urashima et al., “Interactions between serum vitamin D levels and vitamin D receptor gene foki polymorphisms for renal function in patients with type 2 diabetes,” PLoS ONE, vol. 7, no. 12, article e51171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Khademvatani, M. H. Seyyed-Mohammadzad, M. Akbari, Y. Rezaei, R. Eskandari, and A. Rostamzadeh, “The relationship between vitamin D status and idiopathic lower-extremity deep vein thrombosis,” International Journal of General Medicine, vol. 7, pp. 303–309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Uysal, A. G. Kalayci, and K. Baysal, “Cardiac functions in children with vitamin D deficiency rickets,” Pediatric Cardiology, vol. 20, no. 4, pp. 283–286, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Donate-Correa, V. Domínguez-Pimentel, M. L. Méndez-Pérez et al., “Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease,” Mediators of Inflammation, vol. 2014, Article ID 670475, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Esen, A. E. Atay, I. Sahin et al., “The relation of serum 25-hydroxy vitamin D3 with inflammation and indirect markers of thrombotic activity in patients with end stage renal disease,” Journal of Clinical and Experimental Nephrology, vol. 1, pp. 1–6, 2016. View at Google Scholar
  28. S. Lai, A. Molfino, G. E. Russo et al., “Cardiac, inflammatory and metabolic parameters: hemodialysis versus peritoneal dialysis,” Cardiorenal Medicine, vol. 5, no. 1, pp. 20–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. A. N. Kiani, H. Fang, L. S. Magder, and M. Petri, “Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus,” Rheumatology, vol. 52, no. 11, pp. 2071–2076, 2013. View at Publisher · View at Google Scholar
  30. S. Lemmilä, H. Saha, V. Virtanen, I. Ala-Houhala, and A. Pasternack, “Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis,” American Journal of Nephrology, vol. 18, no. 5, pp. 404–410, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. N. P. Singh, V. Sahni, D. Garg, and M. Nair, “Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis CKD patients: a preliminary observation,” Hemodialysis International, vol. 11, no. 4, pp. 417–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. C. W. Park, Y. S. Oh, Y. S. Shin et al., “Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism,” American Journal of Kidney Diseases, vol. 33, no. 1, pp. 73–81, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Thadhani, E. Appelbaum, Y. Pritchett et al., “Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial,” The Journal of the American Medical Association, vol. 307, no. 7, pp. 674–684, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Y.-M. Wang, F. Fang, J. Chan et al., “Effect of paricalcitol on left ventricular mass and function in CKD-the OPERA trial,” Journal of the American Society of Nephrology, vol. 25, no. 1, pp. 175–186, 2014. View at Publisher · View at Google Scholar · View at Scopus